Atara Biotherapeutics (ATRA) Current Leases (2019 - 2026)
Atara Biotherapeutics (ATRA) posted Current Leases of $1.0 million for Q1 2026, down 1.36% on a QoQ basis from $1.0 million in Q4 2025, and down 5.23% year-over-year from $1.1 million in Q1 2025.
Atara Biotherapeutics (ATRA) Current Leases (2019 - 2026) Analysis & Trends
Atara Biotherapeutics' Current Leases history runs 8 years deep, the most recent figure standing at $1.0 million for Q1 2026.
- Quarterly Current Leases fell 5.23% year-over-year to $1.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.0 million (down 5.23% YoY) and the FY2025 annual result came in at $1.0 million, down 92.02% from the prior year.
- Current Leases was $1.0 million for Q1 2026 at Atara Biotherapeutics, down from $1.0 million in the prior quarter.
- Across five years, Current Leases topped out at $13.1 million in Q1 2024 and bottomed at $832000.0 in Q1 2023.
- A 5-year average of $5.6 million and a median of $1.1 million in 2025 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2024 — Current Leases surged 1472.96% — and 2025, when it sank 92.02%.
- Atara Biotherapeutics' Current Leases stood at $834000.0 in 2022, then climbed by 9.71% to $915000.0 in 2023, then soared by 1307.54% to $12.9 million in 2024, then sank by 92.02% to $1.0 million in 2025, then decreased by 1.36% to $1.0 million in 2026.
- Business Quant data shows ATRA's Current Leases at $1.0 million in Q1 2026, $1.0 million in Q4 2025, and $2.2 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 20.58 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 16.61 Mn |
| 10 | Atara Biotherapeutics | 110.04 Mn | 101.68 Mn | 392,000.00 | 1.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.01 Mn |
| Dec 31, 2025 | 1.03 Mn |
| Jun 30, 2025 | 2.24 Mn |
| Mar 31, 2025 | 1.07 Mn |
| Dec 31, 2024 | 12.88 Mn |
| Sep 30, 2024 | 1.01 Mn |
| Jun 30, 2024 | 13.02 Mn |
| Mar 31, 2024 | 13.09 Mn |
| Dec 31, 2023 | 915,000.00 |
| Sep 30, 2023 | 12.41 Mn |
| Jun 30, 2023 | 12.10 Mn |
| Mar 31, 2023 | 832,000.00 |
| Dec 31, 2022 | 834,000.00 |
| Dec 31, 2021 | 2.58 Mn |
| Dec 31, 2020 | 1.73 Mn |
| Dec 31, 2019 | 1.31 Mn |